Psychological burden in adult neurofibromatosis type 1 patients: Impact of disease visibility on body image

Dermatology

Volumn 224, Issue 2, 2012, Pages 160-167

  Granstörm, Sofia ^a   Langenbruch, Anna ^a   Augustin, Matthias ^a   Mautner, Victor Felix ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Body image; Disease visibility; Neurofibromatosis type 1; Psychosocial aspects

Indexed keywords

ADULT; ARTICLE; BODY IMAGE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE;

ADOLESCENT; ADULT; AGED; BODY IMAGE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84861842082     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000337548     Document Type: Article

References (27)

1. Lammert M, Friedman JM, Kluwe L, Mautner VF: Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 2005; 141: 71-74. (Pubitemid 40144442)
2. Duong TA, Bastuji-Garin S, Valeyrie-Allanore L, Sbidian E, Ferkal S, Wolkenstein P: Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients. Dermatology 2011; 222: 269-273.
3. Ferner RE: Neurofibromatosis 1. Eur J Hum Genet 2006; 15: 131-138. (Pubitemid 46111848)
4. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y: The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6: 383-392. (Pubitemid 43128290)
5. Ongenae K, Beelaert L, van Geel N, Naeyaert JM: Psychosocial effects of vitiligo. J Eur Acad Dermatol Venerol 2006; 20: 1-8.
6. Gupta MA, Gupta AK, Ellis CN, Koblenzer CS: Psychiatric evaluation of the dermatology patient. Dermatol Clin 2005; 23: 591-599. (Pubitemid 41169831)
7. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P: Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
8. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A: Visibility of neurofibromatosis 1 and psychiatric morbidity. Arch Dermatol 2003; 139: 103-104.
9. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A: Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol 2001; 137: 1421-1425. (Pubitemid 33064237)
10. Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P: Impact of neurofibromatosis 1 on quality of life: a cross-sectional study of 176 American cases. Am J Med Genet 2006; 140A:1893-1898. (Pubitemid 44380075)
11. Kodra Y, Giustini S, Divona L, Porciello R, Calvieri S, Wolkenstein P, Taruscio D: Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients. Dermatology 2009; 218: 215-220.
12. Rumsey N, Harcourt D: Body image and disfigurement: issues and interventions. Body Image 2004; 1: 83-97. (Pubitemid 40105796)
13. Schilder P: The Image and Appearance of the Human Body: Studies in the Constructive Energies of the Psyche. New York, International University Press, 1950.
14. Strauß B, Appelt H: Erfahrungen mit einem Fragebogen zum Körpererleben; in Brähler E (ed): Körpererleben. Ein subjektiver Ausdruck von Körper und Seele. Gießen, Psychosozial-Verlag, 1995, pp 220-231.
15. Brähler E, Strauß B, Hessel A, Schumacher J: Standardization of the 'Fragebogen zur Beurteilung des eigenen Körpers' (FBeK) in a community-based sample of the German population. Diagnostica 2000; 46: 156-164.
16. Strauß B, Appelt H: Ein Fragebogen zur Beurteilung des eigenen Körpers. Diagnostica 1983; 29: 145-164.
17. Strauß B, Richter U Appelt H: Fragebogen zur Beurteilung des eigenen Körpers (FBeK): Handanweisung (Originalfassung und Revision). Göttingen, Hogrefe, 1996.
18. Riccardi VM: Von Recklinghausen Neurofibromatosis. New Engl J Med 1981; 305: 1617-1627.
19. Mehnert A, Müller D, Lehmann C, Koch U: Die deutsche Version des NCCN Distress-Thermometers. Empirische Prüfung eines Screening-Instruments zur Erfassung psychosozialer Belastung bei Krebspatienten. Z Psychiatr Psychol Psychother 2006; 54: 213-223. (Pubitemid 44139610)
20. Finlay A, Khan G: Dermatology Life Quality Index (DLQI) -a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
21. Cohen J: Statistical Power Analysis for the Behavioral Sciences. New York, Erlbaum, 1988.
22. Baron RM, Kenny DA: The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986; 51: 1173-1182.
23. Sobel M: Asymptotic confidence intervals for indirect effects in structural equations models; in Leinhart S (ed): Sociological Methodology. San Francisco, Jossey-Bass, 1982, pp 290-312.
24. Cash TF, Deagle EA: The nature and extent of body-image disturbances in anorexia nervosa and bulimia nervosa: a meta-analysis. Int J Eating Disord 1997; 22: 107-125. (Pubitemid 27328384)
25. Harris D: Types, causes and physical treatment of visible differences; in Lansdown R, Rumsey N, Bradbury E, Carr T, Partridge J (eds): Visibly Different: Coping with Disfigurement. Oxford, Butterworth-Heinemann, 1997, pp 79-90.
26. Thompson A, Kent G: Adjusting to disfigurement: processes involved in dealing with being visibly different. Clin Psychol Rev 2001; 21: 663-682. (Pubitemid 32564934)
27. Stewart TM: Light on body image treatment: acceptance through mindfulness. Behav Modif 2004; 28: 783-811.